Neuro Vigor Therapeutics

We develop solutions in neurotrauma, neuropathic pain, and neurodegenerative disease focused on reducing toxic reactive aldehyde species (RAS) to restore health

[Neuro Vigor Therapeutics @NeuroVigor]

Neuro Vigor is seeking preclinical and clinical collaborators interested in studying the impact of reactive aldehyde species (RAS) in various disease states.

Learn more from our website:
https://t.co/cGetl1mUnT

[Purdue Research Foundation @PurdueResFound]

Just announced!
#Purdue-affiliated Neuro Vigor has signed a drug development collaboration agreement w the University of Western Australia to develop new drugs to treat spinal cord injuries & neurological disease.

🔗https://t.co/PmzWTxs27i @UWAresearch @NeuroVigor

[Nick @docdocrace]

Excited to join this year's @praxis_sci Incubate cohort to propel our science/ideas at @NeuroVigor forward. Congratulations to each of the other companies joining us this cycle!

[Praxis Spinal Cord Institute @praxis_sci]

The Praxis #SCIIncubate 2021/22 Cohort is here! We are excited to announce the five emerging companies that will work closely with the Praxis team to address healthcare outcomes for the SCI community. https://t.co/dbgvL3mMC0